Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study.

BMC Musculoskelet Disord · 2011 · PMC3226526 · PMID 22093579

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

When patients were classified according to prior experience with a BDMARD, a clear trend in clinical responses was observed: patients naïve to BDMARD therapy typically demonstrated greater clinical effectiveness when compared with patients who had experienced prior BDMARD therapy, despite comparable baseline disease characteristics (data not shown).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.